BOH (drug)
Systematic (IUPAC) name | |
---|---|
2-(1,3-benzodioxol-5-yl)-2-methoxyethanamine | |
Clinical data | |
MedlinePlus | a609035 |
Legal status | Uncontrolled |
Routes | Oral |
Identifiers | |
CAS number | 73304-06-0 |
ATC code | None |
PubChem | CID 44719487 |
ChemSpider | 21106264 |
Synonyms | 3,4-methylenedioxy-β-methoxyphenethylamine |
Chemical data | |
Formula | C10H13NO3 |
Mol. mass | 195.22 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
BOH, also known as 3,4-methylenedioxy-β-methoxyphenethylamine, is a drug of the phenethylamine class.[1] It is the β-methoxy analogue of methylenedioxyphenethylamine (MDPEA), and is also more distantly related to methylone. On account of its similarity to norepinephrine, the effects of BOH may be of a purely adrenergic nature.[1]
BOH was first synthesized by Alexander Shulgin.[1] In his book PiHKAL, the dosage range is listed as 80–120 mg, and the duration listed as 6–8 hours. Shulgin reports that BOH causes slight warmth, mydriasis, anorexia, mild nausea, and cold feet, with no psychedelic, entactogen, or euphoriant effects.[1] He gives it a ++ on the Shulgin Rating Scale.[1] Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of BOH.
See also
References
External links
|
|